R. Cohen

Performance of Immunoassays for CA 19-9, CA 15-3 and CA 125 Tumour Markers Evaluated from an International Quality Assessment Survey

G. Zucchelli, M. R. Chiesa, C. Bizollon, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Recommendations for the application and the follow-up of quality controls in medical biology laboratories.

R. Cartier, A. Vassault, J. Bouilloux, 2019, Annales de biologie clinique.

[Quality specifications and allowable standards for validation of methods used in clinical biochemistry].

J. Bienvenu, A. Vassault, D. Grafmeyer, 1999, Annales de biologie clinique.

Analytical performance of free PSA immunoassays: results from an interlaboratory survey.

G. Zucchelli, M. R. Chiesa, C. Bizollon, 1997, Clinical chemistry.

Retrospective analysis of 55,769 HbA1c EQA results obtained from professional laboratories and medical offices participating in surveys organized by two European EQA centers over a nine‐year period

Pierre-Alain Morandi, André Deom, Dagmar Kesseler, 2011, Journal of clinical laboratory analysis.

Growing use of nonisotopic CA 19-9 immunoassays increases between-laboratory variability.

G. Zucchelli, M. R. Chiesa, C. Bizollon, 1993, Clinical Chemistry.

Comparison of Immunoassays for Tumor Markers CA 19-9, CA 15-3 and CA 125: Data from an International Quality Assessment Scheme

A Pilo, M Gion, M. Gion, 1995, Tumori.

French interlaboratory cyclosporine quality assessment scheme.

C. Bizollon, R. Cohen, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data

R. Cartier, K. Chikh, R. Cohen, 2015, Clinical chemistry and laboratory medicine.